One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Accesshttps://doi.org/10.1200/jco.2015.33.15_suppl.5525
Copy DOI Journal: Journal of Clinical Oncology |  Publication Date: May 20, 2015 |
 Citations: 1 |
Affiliation: The University of Texas MD Anderson Cancer Center, Saitama Medical University, Oklahoma State University Oklahoma City, University of Oklahoma Health Sciences Center, University of California, Irvine Medical Center, University of California, Irvine, University of Cincinnati, Samsung (South Korea), Sidney Kimmel Cancer Center, NRG Oncology, The Ohio State University, Memorial Sloan Kettering Cancer Center5525 Purpose: GOG 213 is a bifactorial, phase III, randomized trial studying the efficacy and tolerability of the incorporation of B and secondary cytoreduction in women with platinum sensitive rec...
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
